They generated HCT-116 CRC cell lines expressing either the wild-type MTHFD2 protein or a mutant MTHFD2ΔNAD, which lacks the dehydrogenase activity due to a mutation in the NAD-binding site. Here, MTHFD2 is linked to colorectal carcinoma.